Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.55% to 1,670.50 Indian rupees Wednesday, on what proved to be an all-around positive trading session for the stock market, with the BSE ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.14% to 1,661.65 Indian rupees Monday, on what proved to be an all-around dismal trading session for the stock market, with the BSE ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) has unveiled new data at the 2025 Psych Congress Elevate, highlighting significant advances in schizophrenia treatment.

'Pharmageddon,' a documentary directed by Donal O'Neill and produced by cardiologist Aseem Malhotra, was launched recently at Cannes.

Shares of Sun Pharmaceutical Industries gained 1.79% in today's session, with the stock price reaching Rs 1,738.30. The increase reflects positive movement in the stock during today's trading.

With a marginal increase in price and a significant surge in trading volume, Sun Pharmaceutical Industries remains a key stock to watch in the NIFTY 50 STOCKS index.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA. Teva Pharmaceutical ...

New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump administration.

Share Price as of the Close of February 21: $16.74 Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a global leader in the pharmaceutical industry which is primarily focused on generic drugs.